We are live on ! Find out more
MRCM

M&R Capital Management Portfolio holdings

AUM $454M
1-Year Est. Return 40.11%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+40.11%
3 Year Est. Return
+52.56%
5 Year Est. Return
+141.03%
10 Year Est. Return
+275.44%
AUM
$419M
AUM Growth
+$10.9M
Cap. Flow
+$2.31M
Cap. Flow %
0.55%
Top 10 Hldgs %
47.82%
Holding
559
New
11
Increased
126
Reduced
102
Closed
12

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$8.37M
2
CACI icon
CACI
CACI
+$5.74M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$2.32M
4
PEP icon
PepsiCo
PEP
+$1.38M
5
ACGL icon
Arch Capital
ACGL
+$1.25M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$8.98M
2
CMCSA icon
Comcast
CMCSA
+$2.47M
3
LW icon
Lamb Weston
LW
+$2.32M
4
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$1.3M
5
MMM icon
3M
MMM
+$1.04M

Sector Composition

Rank Sector Weight
1 Technology 27.36%
2 Financials 20.03%
3 Healthcare 10.65%
4 Communication Services 9.1%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDU icon
376
MDU Resources
MDU
$4.16B
$9.6K ﹤0.01%
691
+3
+0.4% +$41
IFF icon
377
International Flavors & Fragrances
IFF
$22.4B
$9.52K ﹤0.01%
100
-2
-2% -$183
OGN icon
378
Organon & Co
OGN
$3.61B
$9.46K ﹤0.01%
457
IWX icon
379
iShares Russell Top 200 Value ETF
IWX
$4.04B
$9.28K ﹤0.01%
124
PGX icon
380
Invesco Preferred ETF
PGX
$3.72B
$9.23K ﹤0.01%
799
MATW icon
381
Matthews International
MATW
$653M
$9.15K ﹤0.01%
365
+106
+41% +$2.91K
SGOL icon
382
abrdn Physical Gold Shares ETF
SGOL
$7.45B
$8.89K ﹤0.01%
+400
New +$8.94K
UCC icon
383
ProShares Ultra Consumer Discretionary
UCC
$9.19M
$8.78K ﹤0.01%
244
VWO icon
384
Vanguard FTSE Emerging Markets ETF
VWO
$127B
$8.75K ﹤0.01%
200
DOX icon
385
Amdocs
DOX
$6.57B
$8.68K ﹤0.01%
110
COKE icon
386
Coca-Cola Consolidated
COKE
$13.2B
$8.68K ﹤0.01%
80
SNA icon
387
Snap-on
SNA
$20.3B
$8.64K ﹤0.01%
33
+1
+3% +$275
NUV icon
388
Nuveen Municipal Value Fund
NUV
$1.89B
$8.63K ﹤0.01%
1,000
WHR icon
389
Whirlpool
WHR
$2.68B
$8.6K ﹤0.01%
84
+1
+1% +$97
ITOT icon
390
iShares Core S&P Total US Stock Market ETF
ITOT
$97.4B
$8.43K ﹤0.01%
71
SAN icon
391
Banco Santander
SAN
$213B
$8.31K ﹤0.01%
1,794
LLYVA icon
392
Liberty Live Group Series A
LLYVA
$9.19B
$8.06K ﹤0.01%
215
CTRA
393
DELISTED
Coterra Energy
CTRA
$8K ﹤0.01%
300
NEM icon
394
Newmont
NEM
$135B
$7.83K ﹤0.01%
187
NEA icon
395
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.39B
$7.76K ﹤0.01%
677
SPSB icon
396
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.5B
$7.69K ﹤0.01%
259
CASY icon
397
Casey's General Stores
CASY
$28B
$7.63K ﹤0.01%
20
LH icon
398
Labcorp
LH
$27.2B
$7.53K ﹤0.01%
37
-200
-84% -$40.7K
NVG icon
399
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.63B
$7.53K ﹤0.01%
604
TSLA icon
400
Tesla
TSLA
$1.38T
$7.52K ﹤0.01%
38

Similar funds

M&R Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, M&R Capital Management held 559 positions worth $419M, up 2.7% from $408M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 4.1%. M&R Capital Management opened 11 new positions and exited 12, leaving the 559-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • M&R Capital Management's largest Q2 2024 buy was KeyCorp: 11,973 shares worth $170K.
  • M&R Capital Management added most to AstraZeneca in Q2 2024, an estimated $8.37M increase.
  • M&R Capital Management's biggest Q2 2024 reduction was CVS Health, cutting an estimated $8.98M.
  • M&R Capital Management fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $42.7K.
  • M&R Capital Management's ten largest holdings make up 48% of its $419M portfolio in Q2 2024.
  • M&R Capital Management opened 11 new positions and closed 12 in Q2 2024.
  • M&R Capital Management's portfolio value rose 2.7% quarter-over-quarter to $419M.

Based on M&R Capital Management's 13F filing for Q2 2024, filed 2 Jul 2024.